Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xing Chang
Institutions:
Soochow University,
The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)
Observed institutions:
Shenyang Pharmaceutical University,
Soochow University,
China Academy of Chinese Medical Sciences,
Guang’anmen Hospital,
The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)
ORCID:
0000-0001-6888-4752
Observed ORCID:
0000-0001-6888-4752
OpenAlex ID:
A5108673138
Potential of natural drug modulation of endoplasmic reticulum stress in the treatment of myocardial injury
2024
·
Kai Yang
, Ping Zhang
, et al.
·
Journal of Pharmaceutical Analysis
·
146
Resistance mechanisms and potent-targeted therapies of ROS1-positive lung cancer
2019
·
Annie Roys
, Xing Chang
, et al.
·
Cancer Chemotherapy and Pharmacology
·
59
The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy
2021
·
Patience Setordzi
, Xing Chang
, et al.
·
European Journal of Pharmacology
·
46
3‐(3‐Methoxyphenyl)‐6‐(3‐amino‐4‐methoxyphenyl)‐7H‐[1,2,4] triazolo [3,4‐b][1,3,4] thiadiazine, a novel tubulin inhibitor, evokes G2/M cell cycle arrest and apoptosis in SGC‐7901 and HeLa cells
2019
·
Zi Liu
, Binyue Lang
, et al.
·
Journal of Cellular Biochemistry
·
23
A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non–small cell lung cancers
2022
·
Zi Liu
, Liancheng Huang
, et al.
·
Journal of Biological Chemistry
·
20
Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT
2023
·
Xing Chang
, Jingang Liu
, et al.
·
Biochemical Pharmacology
·
18
FAT4 activation inhibits epithelial-mesenchymal transition (EMT) by promoting autophagy in H2228/Cer cells
2022
·
Yuying Yang
, Yang Li
, et al.
·
Medical Oncology
·
17
Metastasis manners and the underlying mechanisms of ALK and ROS1 rearrangement lung cancer and current possible therapeutic strategies
2019
·
Xing Chang
, Zi Liu
, et al.
·
RSC Advances
·
12
2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines
2018
·
Dayong Zheng
, Xing Chang
, et al.
·
Cancer Biology & Therapy
·
10
PDF
Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis
2022
·
Xing Chang
, Zi Liu
, et al.
·
Toxicology and Applied Pharmacology
·
9
A novel ALK inhibitor ZYY inhibits Karpas299 cell growth in vitro and in a mouse xenograft model and induces protective autophagy
2019
·
Jiwei Shen
, Junfang Wang
, et al.
·
Toxicology and Applied Pharmacology
·
9
Design, synthesis and biological evaluation of colchicine glycoconjugates as tubulin polymerization inhibitors
2022
·
Zhan Wang
, Runlai Liu
, et al.
·
Bioorganic & Medicinal Chemistry
·
6
Comparative Toxicovigilance of Capmatinib and Tepotinib in NSCLC: Respiratory Signal Detection and Adverse Event Profiling via FAERS
2025
·
Xing Chang
, Danyan Shao
, et al.
·
Journal of Biochemical and Molecular Toxicology
·
1
1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42) inhibits cell proliferation and induces apoptosis via inhibiting ALK and its downstream pathways in Karpas299 cells
2022
·
Xing Chang
, Junfang Wang
, et al.
·
Toxicology and Applied Pharmacology
·
1
Kurarinone protects against neuronal ferroptosis and restores iron homeostasis through an ERα-associated NRF2/FTH1 pathway in cellular and animal models of Parkinson’s disease
2026
·
Xing Chang
, Yi-xuan Wang
, et al.
·
Biological Research
Show more works
View as search
Works count:
15
Citation count:
377
H-index:
9
I10-index:
9
Year
Topic
Type